Aquí encontrará nuestros anuncios más recientes, que incluyen asociaciones, lanzamientos de productos y éxitos de pruebas. Lea a continuación para conocer nuestros anuncios más recientes.
ObvioHealth, a global medical technology company, announces the launch of its mobile application for site-less clinical studies.
ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital data capture to remotely monitor patient vitals.
ObvioHealth, a full-service virtual research organization (VRO), announces today a partnership with La Foundation Hôpital Paris Saint Joseph to monitor COVID-19
ObvioHealth, a leading virtual health research organization or VRO, announced today it has raised $17 million in its latest round of financing. This round of financing comes on the heels of a global alliance with a strategic partner announced in March.
Singapore and New-York, 2 April 2020 – ObvioHealth, a digital research company, announces the launch of a registry to monitor COVID-19 prevalence, symptoms and immune response in the United States over the coming 12 months.